150 related articles for article (PubMed ID: 30659903)
1. Use of MRI-Guided Biopsy for Selection and Follow-up of Men Undergoing Hemi-gland Cryoablation of Prostate Cancer.
Zhou SR; Simopoulos DN; Jayadevan R; Felker ER; Delfin MK; Barsa DE; Kwan L; Marks LS
Urology; 2019 Apr; 126():158-164. PubMed ID: 30659903
[TBL] [Abstract][Full Text] [Related]
2. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging-ultrasound fusion guided focal cryoablation for men with intermediate-risk prostate cancer.
Sidana A; Tayebi S; Blank F; Lama DJ; Meyer M; Saeed Y; Tobler J; Hsu WW; Verma S
Urol Oncol; 2024 May; 42(5):158.e1-158.e10. PubMed ID: 38245407
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
[TBL] [Abstract][Full Text] [Related]
5. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.
Bahn D; de Castro Abreu AL; Gill IS; Hung AJ; Silverman P; Gross ME; Lieskovsky G; Ukimura O
Eur Urol; 2012 Jul; 62(1):55-63. PubMed ID: 22445223
[TBL] [Abstract][Full Text] [Related]
6. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer.
Durand M; Barret E; Galiano M; Rozet F; Sanchez-Salas R; Ahallal Y; Macek P; Gaya JM; Cerruti J; Devilliers H; Loeffler J; Amiel J; Vallancien G; Cathelineau X
BJU Int; 2014 Jan; 113(1):56-64. PubMed ID: 24053685
[TBL] [Abstract][Full Text] [Related]
7. Cryotherapy for partial gland ablation of prostate cancer: Oncologic and safety outcomes.
Aker MN; Brisbane WG; Kwan L; Gonzalez S; Priester AM; Kinnaird A; Delfin MK; Felker E; Sisk AE; Kuppermann D; Marks LS
Cancer Med; 2023 Apr; 12(8):9351-9362. PubMed ID: 36775929
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: A prospective development study.
Valerio M; Shah TT; Shah P; Mccartan N; Emberton M; Arya M; Ahmed HU
Urol Oncol; 2017 Apr; 35(4):150.e1-150.e7. PubMed ID: 27955940
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience.
Woodrum DA; Kawashima A; Karnes RJ; Davis BJ; Frank I; Engen DE; Gorny KR; Felmlee JP; Callstrom MR; Mynderse LA
Urology; 2013 Oct; 82(4):870-5. PubMed ID: 23910089
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
[TBL] [Abstract][Full Text] [Related]
11. Hemigland Cryoablation of Clinically Significant Prostate Cancer: Intermediate-Term Followup via Magnetic Resonance Imaging Guided Biopsy.
Chuang R; Kinnaird A; Kwan L; Sisk A; Barsa D; Felker E; Delfin M; Marks L
J Urol; 2020 Nov; 204(5):941-949. PubMed ID: 32985924
[TBL] [Abstract][Full Text] [Related]
12. Focal cryoablation for unilateral low-intermediate-risk prostate cancer: 63-month mean follow-up results of 41 patients.
Lian H; Zhuang J; Yang R; Qu F; Wang W; Lin T; Guo H
Int Urol Nephrol; 2016 Jan; 48(1):85-90. PubMed ID: 26531063
[TBL] [Abstract][Full Text] [Related]
13. Whole-Gland Prostate Cancer Cryoablation with Magnetic Resonance Imaging Guidance: One-Year Follow-Up.
Kinsman KA; White ML; Mynderse LA; Kawashima A; Rampton K; Gorny KR; Atwell TD; Felmlee JP; Callstrom MR; Woodrum DA
Cardiovasc Intervent Radiol; 2018 Feb; 41(2):344-349. PubMed ID: 29043385
[TBL] [Abstract][Full Text] [Related]
14. Medium Term Outcomes of Focal Cryoablation for Intermediate and High Risk Prostate Cancer: MRI and PSA are Not Predictive of Residual or Recurrent Disease.
Baskin A; Charondo LB; Balakrishnan A; Cowan JE; Cooperberg MR; Carroll PR; Nguyen H; Shinohara K
Urol Oncol; 2022 Oct; 40(10):451.e15-451.e20. PubMed ID: 35851186
[TBL] [Abstract][Full Text] [Related]
15. Outcome and safety of transrectal US-guided percutaneous cryotherapy for localized prostate cancer.
Saliken JC; Donnelly BJ; Brasher P; Ali-Ridha N; Ernst S; Robinson J
J Vasc Interv Radiol; 1999 Feb; 10(2 Pt 1):199-208. PubMed ID: 10082109
[TBL] [Abstract][Full Text] [Related]
16. [Role of transrectal ultrasonography in the follow-up of patients treated with prostatic cryosurgery].
Galosi AB; Muzzonigro G; Polito M; Minardi D; Dellabella M; Lugnani F; Polito M
Arch Ital Urol Androl; 2000 Dec; 72(4):276-81. PubMed ID: 11221054
[TBL] [Abstract][Full Text] [Related]
17. First experiences and results after cryoablation of prostate cancer with histopathological evaluation and imaging-based follow-up.
Peters I; Derlin K; Peperhove MJ; Hensen B; Pertschy S; Wolters M; von Klot CJ; Wacker F; Hellms S
Future Oncol; 2022 May; 18(14):1705-1716. PubMed ID: 35255716
[No Abstract] [Full Text] [Related]
18. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.
Eggener SE; Yousuf A; Watson S; Wang S; Oto A
J Urol; 2016 Dec; 196(6):1670-1675. PubMed ID: 27449263
[TBL] [Abstract][Full Text] [Related]
19. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
[TBL] [Abstract][Full Text] [Related]
20. Whole and hemi-gland cryoablation for primary localized prostate cancer: Short and medium-term oncological and functional outcomes.
Bossier R; Sanguedolce F; Territo A; Vanacore D; Martínez C; Regis F; Gallioli A; Mercade A; Mosquera L; Aumatell J; Balana J; Carlderon J; Huguet J; Gaya JM; Palou J; Breda A
Actas Urol Esp (Engl Ed); 2020 Apr; 44(3):172-178. PubMed ID: 32033834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
